MAY 11, 2020 1:10 PM PDT

Are antihistamines helpful for cancer?

Research recently published in the research journal Allergy suggests that a common antihistamine could improve survival among patients suffering from malignant melanoma, a dangerous form of skin cancer. The study comes from scientists at Lund University in Sweden. 

"Previous studies have shown that the same antihistamines have survival benefits in breast cancer. Now we see the same thing concerning malignant melanoma. However, more research is required to confirm the results", comments Professor Håkan Olsson. 

The research looked at six antihistamines: desloratadine, cetirizine, loratadine, clemastine, ebastine and fexofenadine. They wanted to see how the allergy drugs would impact patients who had been diagnosed with malignant melanoma. To consider these, they pooled data from three registers in Sweden and analyzed the information for 24,562 individuals.

"We observed improved survival among those who used desloratadine and to a certain extent also loratadine, particularly in the age group 65 and older when we compared with those who had not used antihistamines. The use of the other antihistamines showed no significant survival effect. The use of desloratadine and loratadine also seemed to reduce the risk of getting a new malignant melanoma", says Håkan Olsson.

Photo: Pixabay

The researchers are hopeful about the implications of their study and hope to continue their investigations in order to eventually move into clinical trials. "The finding is interesting for a future drug against melanoma and may also help in advanced stages of the disease. In addition, the medicines have virtually no side effects. We are collaborating with researchers in Barcelona and Stockholm. In Lund, we are underway with studies in both animal and human subjects, in which doses of antihistamines will be compared with the patients who do not take antihistamines, in order to measure the treatment effect", concludes Håkan Olsson.

Sources: AllergyEureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 20, 2020
Cancer
Fighting Cancer with Black Pepper
JUL 20, 2020
Fighting Cancer with Black Pepper
In the never-ending search for the next treatment or cure, many researchers turn towards nature. The study of black pepp ...
JUL 28, 2020
Clinical & Molecular DX
Cancer Diagnostics Go Skin Deep
JUL 28, 2020
Cancer Diagnostics Go Skin Deep
The average adult human has between 16 and 22 square feet of skin. This multifaceted organ serves a multitude of functio ...
AUG 05, 2020
Cancer
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
AUG 05, 2020
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
Cell-free DNA (cfDNA) are small pieces of genomic DNA that have escaped into the bloodstream either through active relea ...
AUG 14, 2020
Cancer
Controlling Tumor Blood Flow to Increase Therapy Effectiveness
AUG 14, 2020
Controlling Tumor Blood Flow to Increase Therapy Effectiveness
Nowadays, most cancer drugs target a protein or inhibit a critical cellular process. Modern therapies have varying level ...
SEP 03, 2020
Clinical & Molecular DX
Tiny Diagnostic Robot Tank Explores the Colon
SEP 03, 2020
Tiny Diagnostic Robot Tank Explores the Colon
The colon, also known as the large intestine, is where the final stages of digestion happen. Here, water, salts, and rem ...
SEP 06, 2020
Cancer
Focal HIFU ablation improves prostate cancer patients' quality of life
SEP 06, 2020
Focal HIFU ablation improves prostate cancer patients' quality of life
Research published in The Journal of Urology offers an alternative to invasive prostate cancer treatments like surg ...
Loading Comments...